Navigation Links
LCS Constructors, Inc. Completes First Major Phase of Abraxis BioScience Project
Date:4/29/2010

d. These seismic models were a key element for understanding the purpose and the workings for this project.

"This has been a fantastic client and job to work on," stated Koons. And, although the team faced several unique challenges that accompanied these seismic upgrades, they were resourceful and that, combined with patience, planning and strategy, led to the successful completion of the first major phase of this project.

The relocation of Abraxis' research and development group from Marina Del Rey to Costa Mesa will provide the company more space to grow their operations. LCS was proud to renovate the new facility which will provide the technology necessary to propel Abraxis closer to their goals of finding new treatments for cancer and other pathological disorders.


'/>"/>
SOURCE LCS Constructors, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
4. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
5. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
6. QuatRx Completes Patient Enrollment in Phase 3 Study of Ophena(TM) in Women with Postmenopausal Vaginal Syndrome
7. CryoCor Completes Enrollment of Pivotal Clinical Study for Atrial Fibrillation
8. Anesiva Completes Enrollment in Phase 3 Clinical Trial of Zingo(TM) to Treat Pain Associated With Venous Access Procedures in Adults
9. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
10. Cadence Pharmaceuticals Completes Enrollment of Pivotal Phase III Trial for Intravenous Acetaminophen Ahead of Schedule
11. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... 2014 Baptist Health Lexington is the first facility ... full Atrial Fibrillation with Electrophysiology Services (EPS) Accreditation status from ... fibrillation is the most common cardiac arrhythmia and has become ... lead to stroke and possible death. More than 5 million ... atrial fibrillation and the numbers are rapidly increasing as the ...
(Date:12/17/2014)... DIEGO , Dec. 17, 2014 Royal ... Volcano Corporation (NASDAQ: VOLC ), a global leader ... announced that they have entered into a definitive merger agreement. ... to acquire all of the issued and outstanding shares of ... purchase price of USD 1 billion (approx. EUR 800 million), ...
(Date:12/17/2014)... 2014 With advancements in neurological and ... is seeing new growth, according to Kalorama Information. ... for the majority of market volume, newer 3T ... which are creating opportunities for more sophisticated applications. The ... at a rate of 4%, with world market ...
Breaking Medicine Technology:Baptist Health Lexington First in the Nation to Receive Atrial Fibrillation with EPS Accreditation 2Baptist Health Lexington First in the Nation to Receive Atrial Fibrillation with EPS Accreditation 3Philips to acquire Volcano to expand global leadership position in image-guided therapy market 2Philips to acquire Volcano to expand global leadership position in image-guided therapy market 3Philips to acquire Volcano to expand global leadership position in image-guided therapy market 4Philips to acquire Volcano to expand global leadership position in image-guided therapy market 5Philips to acquire Volcano to expand global leadership position in image-guided therapy market 6Philips to acquire Volcano to expand global leadership position in image-guided therapy market 7Philips to acquire Volcano to expand global leadership position in image-guided therapy market 8Kalorama: 3T Advancements Bringing New Growth to the MRI Market 2Kalorama: 3T Advancements Bringing New Growth to the MRI Market 3
... Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR ) ... Senior Vice President of Research and Development, Cynthia Schwalm ... M.D., as Senior Vice President of Pharmacovigilance. These newly ... the Company prepares for the potential launch of its ...
... Perrigo Company (Nasdaq: PRGO ; TASE) today announced ... Perrigo,s Chairman and CEO Joseph C. Papa commented, "We ... performance. The main contributors to this strong performance were $44 ... Rx and API segments and another solid quarter in Nutritionals. ...
Cached Medicine Technology:Optimer Pharmaceuticals Expands Senior Management Team 2Optimer Pharmaceuticals Expands Senior Management Team 3Optimer Pharmaceuticals Expands Senior Management Team 4Optimer Pharmaceuticals Expands Senior Management Team 5Perrigo Reports Record Quarterly Revenue and Earnings and Raises Full Year Adjusted EPS Guidance 2Perrigo Reports Record Quarterly Revenue and Earnings and Raises Full Year Adjusted EPS Guidance 3Perrigo Reports Record Quarterly Revenue and Earnings and Raises Full Year Adjusted EPS Guidance 4Perrigo Reports Record Quarterly Revenue and Earnings and Raises Full Year Adjusted EPS Guidance 5Perrigo Reports Record Quarterly Revenue and Earnings and Raises Full Year Adjusted EPS Guidance 6Perrigo Reports Record Quarterly Revenue and Earnings and Raises Full Year Adjusted EPS Guidance 7Perrigo Reports Record Quarterly Revenue and Earnings and Raises Full Year Adjusted EPS Guidance 8Perrigo Reports Record Quarterly Revenue and Earnings and Raises Full Year Adjusted EPS Guidance 9Perrigo Reports Record Quarterly Revenue and Earnings and Raises Full Year Adjusted EPS Guidance 10Perrigo Reports Record Quarterly Revenue and Earnings and Raises Full Year Adjusted EPS Guidance 11Perrigo Reports Record Quarterly Revenue and Earnings and Raises Full Year Adjusted EPS Guidance 12Perrigo Reports Record Quarterly Revenue and Earnings and Raises Full Year Adjusted EPS Guidance 13Perrigo Reports Record Quarterly Revenue and Earnings and Raises Full Year Adjusted EPS Guidance 14Perrigo Reports Record Quarterly Revenue and Earnings and Raises Full Year Adjusted EPS Guidance 15Perrigo Reports Record Quarterly Revenue and Earnings and Raises Full Year Adjusted EPS Guidance 16Perrigo Reports Record Quarterly Revenue and Earnings and Raises Full Year Adjusted EPS Guidance 17Perrigo Reports Record Quarterly Revenue and Earnings and Raises Full Year Adjusted EPS Guidance 18
(Date:12/19/2014)... THURSDAY, Dec. 18, 2014 (HealthDay News) -- The tragic death ... the risk carried by the pet rodents, according to a ... "Rat-bite fever is a rare but potentially fatal illness ... joint pain, and when a history of rodent exposure is ... the CDC,s Epidemic Intelligence Service. The case outlined in ...
(Date:12/19/2014)... HealthDay Reporter THURSDAY, Dec. 18, ... slightly reduce your risk of developing a form of ... Motrin) and naproxen (Aleve) appear to reduce the risk ... researchers concluded after reviewing nine prior studies. Squamous cell ... These painkillers "have potential as part of ...
(Date:12/19/2014)... analogue eye drops -- a common form of glaucoma ... in patients with the eye disease, a new study ... the Moorfields Eye Hospital and UCL Institute of Ophthalmology ... newly diagnosed with open-angle glaucoma -- the most common ... causes of blindness. About 45 million people worldwide ...
(Date:12/17/2014)... December 17, 2014 While countless companies tempt ... not realize the potential dangers of their purchase. Not only ... from a qualified doctor, but patients who buy hCG online ... that there is actually no real hCG present. Illegal internet ... there are no safety standards and may contain unknown fillers ...
(Date:12/17/2014)... Marlborough, Mass. (PRWEB) December 17, 2014 ... College of Osteopathic Medicine (ACOM), which welcomed its ... Virtual Desktop Infrastructure (VDI) to seamlessly support bring ... learning – and teaching – experience. The solution, ... Citrix NetScaler , Dell server and storage ...
Breaking Medicine News(10 mins):Health News:Scratch From Pet Rat Kills Child; CDC Warns of Risk 2Health News:Common Painkillers May Help Prevent Certain Skin Cancers, Study Finds 2Health News:Common Painkillers May Help Prevent Certain Skin Cancers, Study Finds 3Health News:Study Supports Benefit of Widely Used Glaucoma Drug 2Health News:Diet Doc Reveals the Real Dangers for Those who Buy hCG Online 2Health News:Diet Doc Reveals the Real Dangers for Those who Buy hCG Online 3Health News:Alabama College of Osteopathic Medicine Deploys Desktop Virtualization Solution from Citrix, Dell and Unidesk 2Health News:Alabama College of Osteopathic Medicine Deploys Desktop Virtualization Solution from Citrix, Dell and Unidesk 3
... -- In findings that may lead to clinical trials of ... Israel Deaconess Medical Center (BIDMC) and their colleagues have identified ... drug can reverse kidney damage in mouse models of diabetes, ... The study builds on a discovery that, in mice, ...
... By Denise Mann HealthDay Reporter , TUESDAY, ... hormone replacement therapy to stave off hot flashes, night sweats ... for developing breast cancer down the road, a news study ... dramatically after a large government-run trial, the U.S. Women,s Health ...
... (Boston) A new study conducted by Boston University School ... students in Yemen believe that chewing the plant khat is ... patients to quit. The study, which is published online ... BUSM class of 2013 students Paul Yi, John Kim and ...
... near manufacturing industries, a breath of air may ... location, finds a recent study involving a Kansas ... of geology at Kansas State University, along with ... School of Public Health and Department of Environmental ...
... benefit from internet-based therapy just as much as patients ... the findings of a German-Swedish study in which patients ... of therapy over a ten-week period. The outcome of ... significantly better than that of a control group that ...
... Reporter , TUESDAY, March 6 (HealthDay News) -- New research ... longevity in humans by showing that genetically modified mice live ... a few differences between mice and humans, especially in regard ... genetic tweak, so there,s no way to know if the ...
Cached Medicine News:Health News:Study targets key molecule to reverse kidney damage in mice 2Health News:Study targets key molecule to reverse kidney damage in mice 3Health News:Estrogen-Only Therapy May Reduce Breast Cancer Risk 2Health News:Estrogen-Only Therapy May Reduce Breast Cancer Risk 3Health News:Estrogen-Only Therapy May Reduce Breast Cancer Risk 4Health News:BUSM student-published study focuses on khat chewing in Yemeni culture 2Health News:Manganese concentrations higher in residential neighborhoods than industrial sites, varies by region 2Health News:Manganese concentrations higher in residential neighborhoods than industrial sites, varies by region 3Health News:Internet-based therapy relieves persistent tinnitus 2Health News:Genetic Tweak Helps Mice Avoid Cancer, Obesity: Study 2
... what you want and Tomey delivers. The ... oz.) and is the best equipment to ... Measurement System will allow measurements without looking ... provides easy-toread information. Thermal built-in printer and ...
World's first commercially available vacuum assisted biopsy device for MRI....
... Now you can perform stereotactic, ultrasound and ... convenience of your office. Use the patented, ... easier and more clinically advanced method of ... best for the women who trust YOU.,12 ...
... you can perform stereotactic, ultrasound and MRI-guided ... of your office. Use the patented, FDA-cleared ... and more clinically advanced method of breast ... for the women who trust YOU.,9 Gauge ...
Medicine Products: